Aliases & Classifications for Alopecia

Summaries for Alopecia

Disease Ontology : 12 A hypotrichosis that is characterized by a loss of hair from the head or body.

MalaCards based summary : Alopecia is related to hypotrichosis 4 and microcephaly, and has symptoms including exanthema and pruritus. An important gene associated with Alopecia is HR (HR, Lysine Demethylase And Nuclear Receptor Corepressor), and among its related pathways/superpathways are Tuberculosis and Rheumatoid arthritis. The drugs Acitretin and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include Hair and Hair, and related phenotypes are digestive/alimentary and craniofacial

Related Diseases for Alopecia

Diseases related to Alopecia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 457)
id Related Disease Score Top Affiliating Genes
1 hypotrichosis 4 31.0 AIRE HR IFNG IL1A TNF
2 microcephaly 29.7 IFNG TNF VDR
3 nasopharyngitis 29.3 IFNG IL1A TNF
4 pyoderma 29.0 DCAF17 DSP HR MBTPS2 VDR
5 alopecia areata 12.4
6 alopecia universalis 12.3
7 alopecia totalis 12.2
8 frontal fibrosing alopecia 12.2
9 alopecia, androgenetic, 1 12.1
10 alopecia, neurologic defects, and endocrinopathy syndrome 12.1
11 mandibulofacial dysostosis with alopecia 12.1
12 t-cell immunodeficiency, congenital alopecia, and nail dystrophy 12.1
13 central centrifugal cicatricial alopecia 12.1
14 palmoplantar keratoderma and congenital alopecia 2 12.0
15 diffuse alopecia areata 12.0
16 palmoplantar keratoderma with congenital alopecia 12.0
17 androgenic alopecia 12.0
18 alopecia-contractures-dwarfism mental retardation syndrome 12.0
19 alopecia-mental retardation syndrome 1 11.9
20 ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis 11.9
21 polyposis, skin pigmentation, alopecia, and fingernail changes 11.9
22 alopecia areata 1 11.9
23 macrocephaly, alopecia, cutis laxa, and scoliosis 11.9
24 autosomal dominant palmoplantar keratoderma and congenital alopecia 11.8
25 alopecia-epilepsy-oligophrenia syndrome of moynahan 11.7
26 alopecia-intellectual disability syndrome 11.7
27 lichen planopilaris 11.7
28 autosomal recessive palmoplantar keratoderma and congenital alopecia 11.7
29 alopecia, epilepsy, pyorrhea, mental subnormality 11.7
30 woodhouse-sakati syndrome 11.7
31 frontonasal dysplasia with alopecia and genital anomaly 11.6
32 alopecia-mental retardation syndrome 3 11.6
33 hypergonadotropic hypogonadism and partial alopecia 11.6
34 alopecia intellectual disability syndrome 2 11.6
35 thumb deformity and alopecia 11.6
36 alopecia universalis onychodystrophy vitiligo 11.6
37 alopecia areata 2 11.6
38 alopecia-contractures-dwarfism-intellectual disability syndrome 11.6
39 alopecia-mental retardation syndrome 2 11.6
40 alopecia, psychomotor epilepsy, pyorrhea, and mental subnormality 11.6
41 gapo syndrome 11.6
42 alopecia-mental retardation syndrome with convulsions and hypergonadotropic hypogonadism 11.6
43 alopecia, androgenetic, 2 11.6
44 ichthyosis with alopecia, eclabium, ectropion, and mental retardation 11.6
45 thumb deformity, alopecia, pigmentation anomaly 11.6
46 alopecia, androgenetic, 3 11.6
47 ectodermal dysplasia alopecia preaxial polydactyly 11.6
48 odonto onycho dysplasia with alopecia 11.6
49 follicular mucinosis 11.6
50 growth retardation alopecia pseudoanodontia optic 11.6

Graphical network of the top 20 diseases related to Alopecia:



Diseases related to Alopecia

Symptoms & Phenotypes for Alopecia

UMLS symptoms related to Alopecia:


exanthema, pruritus

MGI Mouse Phenotypes related to Alopecia:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.97 HR IFNG KRT14 TNF VDR AIRE
2 craniofacial MP:0005382 9.91 AR DSP EDNRA IFNG KRT14 TNF
3 endocrine/exocrine gland MP:0005379 9.91 VDR AIRE AR EDNRA FOXN1 HR
4 hematopoietic system MP:0005397 9.85 AIRE AR EDNRA FOXN1 HR IFNG
5 integument MP:0010771 9.65 AR DSP EDNRA FOXN1 HR IFNG
6 neoplasm MP:0002006 9.23 AIRE AR FOXN1 HR IFNG IL1A

Drugs & Therapeutics for Alopecia

Drugs for Alopecia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 360)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acitretin Approved Phase 4 55079-83-9 6437841 5284513
2
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
3
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
4
Triamcinolone Approved, Vet_approved Phase 4,Phase 2 124-94-7 31307
5
Finasteride Approved Phase 4,Phase 3,Phase 1,Phase 2 98319-26-7 57363
6
Minoxidil Approved Phase 4,Phase 3,Phase 1,Phase 2 38304-91-5 4201
7
Imiquimod Approved, Investigational Phase 4,Phase 3 99011-02-6 57469
8
Hydroxychloroquine Approved Phase 4 118-42-3 3652
9
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
10
Latanoprost Approved, Investigational Phase 4 130209-82-4 5282380 5311221
11
Capsaicin Approved Phase 4 404-86-4 1548943
12
Bimatoprost Approved, Investigational Phase 4,Phase 2,Phase 1 155206-00-1 5311027
13
Doxorubicin Approved, Investigational Phase 4,Phase 2,Phase 3 23214-92-8 31703
14
Drospirenone Approved Phase 4 67392-87-4 68873
15
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757 53477783
16
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
17
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 5460373 44475014
18
Spironolactone Approved Phase 4,Phase 2 1952-01-7, 52-01-7 5833
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
20
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
21
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 54575, 6560146 143
22
Manganese Approved, Nutraceutical Phase 4 7439-96-5 27854
23
Doxil Approved June 1999 Phase 4,Phase 2,Phase 3 31703
24 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
25
Clobetasol Phase 4,Phase 3 25122-46-7 32798 5311051
26 Dermatologic Agents Phase 4,Phase 3,Phase 1,Phase 2
27 Emollients Phase 4
28 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
29 Hormone Antagonists Phase 4,Phase 3,Phase 1,Phase 2
30 Hormones Phase 4,Phase 3,Phase 1,Phase 2
31 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 1,Phase 2
32 Keratolytic Agents Phase 4
33 Adjuvants, Immunologic Phase 4,Phase 3,Phase 2,Phase 1
34 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
35 Anti-Asthmatic Agents Phase 4,Phase 1,Phase 2
36 Antihypertensive Agents Phase 4,Phase 3,Phase 1,Phase 2
37 Respiratory System Agents Phase 4,Phase 1,Phase 2
38 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
39 Antiemetics Phase 4,Phase 2,Phase 1
40 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1
41 Autonomic Agents Phase 4,Phase 1,Phase 2
42 Gastrointestinal Agents Phase 4,Phase 2,Phase 1
43 Methylprednisolone acetate Phase 4
44 Methylprednisolone Hemisuccinate Phase 4
45 Neuroprotective Agents Phase 4,Phase 2
46 Prednisolone acetate Phase 4
47 Prednisolone hemisuccinate Phase 4
48 Prednisolone phosphate Phase 4
49 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1
50 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 307)
id Name Status NCT ID Phase
1 Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia Unknown status NCT01111981 Phase 4
2 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4
3 Aldara for the Treatment of Extensive Alopecia Areata Completed NCT00177021 Phase 4
4 Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% Completed NCT00176943 Phase 4
5 Plaquenil for Alopecia Areata, Alopecia Totalis Completed NCT00176982 Phase 4
6 Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata Completed NCT02350023 Phase 4
7 Response of Topical Capsaicin in Alopecia Areata Completed NCT00176969 Phase 4
8 Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata Completed NCT01167946 Phase 4
9 Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children Completed NCT01023841 Phase 4
10 Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma Completed NCT00969462 Phase 4
11 Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance Completed NCT01511822 Phase 4
12 Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses Completed NCT00774787 Phase 4
13 Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters Completed NCT01514942 Phase 4
14 A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents Completed NCT01424644 Phase 4
15 Intralesional Steroids in the Treatment of Alopecia Areata Recruiting NCT01898806 Phase 4
16 Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic Alopecia Active, not recruiting NCT02999737 Phase 4
17 The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia Withdrawn NCT02483195 Phase 4
18 Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients Unknown status NCT01655108 Phase 3
19 Reflexology's Effect on Polycystic Ovary Syndrome: A Pilot Study Unknown status NCT00746148 Phase 3
20 Reflexology's Effect on Polycystic Ovary Syndrome (PCOS) Unknown status NCT00744510 Phase 3
21 Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous Unknown status NCT01222000 Phase 3
22 The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis Completed NCT00997815 Phase 2, Phase 3
23 Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata Completed NCT00063076 Phase 2, Phase 3
24 A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia Completed NCT00441116 Phase 3
25 Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia Completed NCT00958750 Phase 3
26 A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata Completed NCT01453686 Phase 3
27 A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss Completed NCT00151515 Phase 3
28 A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia Completed NCT01831791 Phase 3
29 Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia Completed NCT02014584 Phase 3
30 Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Completed NCT01231607 Phase 3
31 Clinical Trial in Females With Female Pattern Hair Loss Completed NCT01145625 Phase 3
32 Clinical Trial in Females for Female Pattern Hair Loss Completed NCT01226459 Phase 3
33 Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) Completed NCT01590238 Phase 3
34 Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss Completed NCT01391156 Phase 3
35 Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) Completed NCT00396175 Phase 3
36 A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp Completed NCT02611804 Phase 3
37 Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis Completed NCT01686152 Phase 3
38 Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest Completed NCT02361216 Phase 3
39 Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) Completed NCT00603798 Phase 3
40 Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) Completed NCT00605176 Phase 3
41 Terbinafine Compared to Griseofulvin in Children With Tinea Capitis Completed NCT00117767 Phase 3
42 Terbinafine Compared to Griseofulvin in Children With Tinea Capitis Completed NCT00117754 Phase 3
43 A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Subjects With Actinic Keratoses Completed NCT02120898 Phase 3
44 Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Completed NCT01426880 Phase 2, Phase 3
45 Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Completed NCT00916409 Phase 3
46 Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis Completed NCT02616601 Phase 3
47 Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma Completed NCT00003350 Phase 3
48 Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT). Completed NCT00185458 Phase 3
49 Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer Completed NCT00486954 Phase 3
50 Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects Completed NCT01162122 Phase 3

Search NIH Clinical Center for Alopecia

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: alopecia

Genetic Tests for Alopecia

Genetic tests related to Alopecia:

id Genetic test Affiliating Genes
1 Alopecia 29

Anatomical Context for Alopecia

MalaCards organs/tissues related to Alopecia:

39
Skin, Thyroid, Prostate, T Cells, Testes, Bone, Breast
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Alopecia:
id Tissue Anatomical CompartmentCell Relevance
1 Hair Hair Follicle Fetal Hair Placode Cells Affected by disease
2 Hair Hair Follicle Fetal Matrix Cells Affected by disease
3 Hair Dermal Papilla Guard Dermal Papilla Cells Affected by disease
4 Hair Hair Follicle Primary Hair Placode Cells Affected by disease

Publications for Alopecia

Articles related to Alopecia:

(show top 50) (show all 1999)
id Title Authors Year
1
Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in Asians. ( 28074524 )
2017
2
Frontal Fibrosing Alopecia: A research letter. ( 28052312 )
2017
3
Review of treatment for alopecia totalis and alopecia universalis. ( 28378336 )
2017
4
Common phenotype and different non-HLA genes in Graves' disease and alopecia areata. ( 27810496 )
2017
5
Reply to: "Plasmacytoid dendritic cell content, clustering, and distribution pattern are useful parameters in differentiating lupus alopecia from lichen planopilaris". ( 28089018 )
2017
6
Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis. ( 28325392 )
2017
7
Association of AHSG with alopecia and mental retardation (APMR) syndrome. ( 28054173 )
2017
8
Trichotillomania: a case report with clinical and dermatoscopic differential diagnosis with alopecia areata. ( 28225970 )
2017
9
Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata. ( 28044367 )
2017
10
Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split-face comparative study. ( 28074525 )
2017
11
Alopecia Following Bicoronal Incisions. ( 28056117 )
2017
12
Whole brain radiotherapy with volumetric-modulated arc therapy for pediatric intracranial embryonic carcinoma prevents permanent alopecia. ( 28042910 )
2017
13
Recovery of hair in the psoriatic plaques of a patient with coexistent alopecia universalis. ( 28492603 )
2017
14
Reply to "Clusters of CD123(+) plasmacytoid dendritic cells help distinguish lupus alopecia from lichen planopilaris": Plasmacytoid dendritic cell content, clustering, and distribution pattern are useful parameters in differentiating lupus alopecia from lichen planopilaris. ( 28089017 )
2017
15
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients. ( 27816293 )
2017
16
sQuiz your knowledge: Expanding scarring alopecia in a patient with porphyria cutanea tarda. ( 28400347 )
2017
17
Treatment of alopecia universalis with oral alitretinoin: A case report. ( 28349112 )
2017
18
Tofacitinib for the treatment of alopecia areata and variants in adolescents. ( 27816292 )
2017
19
Alopecia areata as a paraneoplastic syndrome of gastric cancer. ( 27990839 )
2017
20
Increased blood levels of NKG2D(+)CD4(+) TA cells in patients with alopecia areata. ( 27986136 )
2017
21
CURRENT AND FUTURE TREATMENTS OF ALOPECIA AREATA AND TRICHOTILLOMANIA IN CHILDREN. ( 27484130 )
2016
22
Frontal Fibrosing Alopecia in Men: Presentations in 12 Cases and a Review of the Literature. ( 27499250 )
2016
23
Radiation-Induced Alopecia after Endovascular Embolization under Fluoroscopy. ( 28074164 )
2016
24
Tissue expansion for correction of alopecia in a child with hypohidrotic ectodermal dysplasia. ( 27177435 )
2016
25
Histopathology of keratotic papules of the limbs in frontal fibrosing alopecia. ( 26956123 )
2016
26
Alopecia Areata Sisaipho: Clinical and Therapeutic Approach in 13 Patients in Spain. ( 27601868 )
2016
27
Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia. ( 28024997 )
2016
28
The role of oxidative stress in early-onset androgenetic alopecia. ( 27987270 )
2016
29
Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients. ( 26979375 )
2016
30
Alopecia Areata as a Manifestation of Systemic Lymphoma: Report of Two Cases. ( 27843927 )
2016
31
Frontal fibrosing alopecia. ( 27294073 )
2016
32
Understanding autoimmunity of vitiligo and alopecia areata. ( 27191524 )
2016
33
Central Centrifugal Cicatricial Alopecia in Children: A Case Series and Review of the Literature. ( 27981623 )
2016
34
Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. ( 27553744 )
2016
35
SU-F-T-218: Validation of An In-Vivo Proton Range Verification Method for Reducing the Risk of Permanent Alopecia in the Treatment of Pediatric Medulloblastoma. ( 28046677 )
2016
36
Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata. ( 27087586 )
2016
37
Alopecia areata (AA) and treatment with simvastatin/ezetimibe: Experience of 20 patients. ( 27085249 )
2016
38
Alopecia areata after denosumab treatment for osteoporosis. ( 27512722 )
2016
39
Postcast hypertrichosis in a patient with frontal fibrosing alopecia. ( 27306714 )
2016
40
Frontal Fibrosing Alopecia. ( 27388531 )
2016
41
Phototherapy for alopecia areata. ( 27638443 )
2016
42
Digit-Length Ratios (2D:4D) as a Phenotypic Indicator of in Utero Androgen Exposure is Not Prognostic for Androgenic Alopecia: a Descriptive-Analytic Study of 1200 Iranian Men. ( 27942367 )
2016
43
Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. ( 27846944 )
2016
44
Multiple courses of pulse corticosteroid therapy for alopecia areata. ( 27095016 )
2016
45
Cocking the eyebrows to find the missing hairline in frontal fibrosing alopecia: A useful clinical maneuver. ( 27444091 )
2016
46
Three hundred and eight nanometer excimer light therapy for alopecia universalis that is resistant to other treatments: A clinical study of 11 patients. ( 27130559 )
2016
47
Follicular mucinosis with diffuse scalp alopecia treated with narrow-band UVB phototherapy: the role of trichoscopy in monitoring therapeutic outcomes. ( 27068601 )
2016
48
Study of the comparative expression of CXCL9, CXCL10 and IFNI^ in vitiligo and alopecia areata patients. ( 27863059 )
2016
49
Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship? ( 27489744 )
2016
50
Cover Image: Detection of hair follicle-associated Merkel cell polyomavirus in an immunocompromised host with follicular spicules and alopecia. ( 27996135 )
2016

Variations for Alopecia

Expression for Alopecia

Search GEO for disease gene expression data for Alopecia.

Pathways for Alopecia

GO Terms for Alopecia

Biological processes related to Alopecia according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.77 AR IFNG IL1A TNF VDR
2 humoral immune response GO:0006959 9.58 AIRE IFNG TNF
3 positive regulation of transcription from RNA polymerase II promoter GO:0045944 9.56 AIRE AR AUTS2 FOXN1 IFNG IL1A
4 negative regulation of growth of symbiont in host GO:0044130 9.49 IFNG TNF
5 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.48 IFNG TNF
6 positive regulation of chemokine biosynthetic process GO:0045080 9.46 IFNG TNF
7 positive regulation of hair follicle development GO:0051798 9.43 FOXN1 TNF
8 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.32 IFNG TNF
9 thymus epithelium morphogenesis GO:0097536 9.26 AIRE FOXN1
10 positive regulation of vitamin D biosynthetic process GO:0060557 9.16 IFNG TNF
11 epidermis development GO:0008544 9.02 DSP EDA2R FOXN1 KRT14 KRT15

Molecular functions related to Alopecia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 androgen binding GO:0005497 8.62 AR SHBG

Sources for Alopecia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....